Machine Learning Assisted Prediction of Prognostic Biomarkers Associated With COVID-19, Using Clinical and Proteomics Data

Abstract

With the availability of COVID-19-related clinical data, healthcare researchers can now explore the potential of computational technologies such as artificial intelligence (AI) and machine learning (ML) to discover biomarkers for accurate detection, early diagnosis, and prognosis for the management of COVID-19. However, the identification of biomarkers associated with survival and deaths remains a major challenge for early prognosis. In the present study, we have evaluated and developed AI-based prediction algorithms for predicting a COVID-19 patient’s survival or death based on a publicly available dataset consisting of clinical parameters and protein profile data of hospital-admitted COVID-19 patients. The best classification model based on clinical parameters achieved a maximum accuracy of 89.47% for predicting survival or death of COVID-19 patients, with a sensitivity and specificity of 85.71 and 92.45%, respectively. The classification model based on normalized protein expression values of 45 proteins achieved a maximum accuracy of 89.01% for predicting the survival or death, with a sensitivity and specificity of 92.68 and 86%, respectively. Interestingly, we identified 9 clinical and 45 protein-based putative biomarkers associated with the survival/death of COVID-19 patients. Based on our findings, few clinical features and proteins correlate significantly with the literature and reaffirm their role in the COVID-19 disease progression at the molecular level. The machine learning–based models developed in the present study have the potential to predict the survival chances of COVID-19 positive patients in the early stages of the disease or at the time of hospitalization. However, this has to be verified on a larger cohort of patients before it can be put to actual clinical practice. We have also developed a webserver CovidPrognosis, where clinical information can be uploaded to predict the survival chances of a COVID-19 patient. The webserver is available at http://14.139.62.220/covidprognosis/.

An artificial neural network classification method employing longitudinally monitored immune biomarkers to predict the clinical outcome of critically ill COVID-19 patients

“…To overcome this issue and grant validity to our findings, we opted to train/test the model with one dataset and use an additional set for validation. In addition, other studies that used biomarkers from clinical cohorts ( Bermejo-Martin et al, 2020 ; Fazolo et al, 2021 ; Sardar, Sharma & Gupta, 2021 ) did not show a substantial improvement in their sample population to ours. Another potential limitation we faced was due to the classificatory nature of this study, which asks for categorical variables ( i.e.…”

Artificial Intelligence Predicts Severity of COVID-19 Based on Correlation of Exaggerated Monocyte Activation, Excessive Organ Damage and Hyperinflammatory Syndrome: A Prospective Clinical Study

“…Nevertheless, this study has the following limitations 1) the predictive models were constructed based on a relatively small sample size (60 patients) therefore the interpretation of our findings might be limited; 2) we only used leave-one-out cross-validation rather than external validation. However, this method was shown to be a valuable tool for building the prediction models ( 73 ). But despite this, the selected factors that allow determination of the severity of COVID-19 are consistent with those previously known in the literature and as more data become available, the whole procedure can easily be repeated to finetune the prediction models.…”

A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19

“…Several published studies provide a computational tool or Web-based calculator for easy use in a variety of settings 10 , 11 , 16 – 20 . Unfortunately, such calculators require data entry that is cumbersome in a busy clinical practice.…”